新西兰头颈癌长期生活质量结局
该研究结合临床记录审计(n=1277)、横断面在线调查(n=195)和半结构化访谈(n=22),探讨新西兰头颈癌患者的长期生存体验。调查显示25%存在语音困难(VHI-10升高)、18%存在抑郁(HADS升高),心理支持是最期望的长期服务。
要点
- 头颈癌幸存者长期存在语音困难和抑郁症状。
- 心理支持是患者最期望的长期服务。
- 治疗后服务匮乏,需倡导长期支持。
核心结论
- 头颈癌长期支持获取困难,倡导长期支持可改善生存体验。
研究设计与样本
- 临床记录审计纳入2012-2023年一家三级癌症中心全部就诊患者(n=1277)。
- 横断面在线调查邀请750例原发治疗后生存超过12个月的患者,195例完成。
- 对全部调查应答者提供半结构化访谈,22例参与。
主要发现
- 患者男性占72%,51-70岁占45%;口腔癌32%,口咽癌21%。
- 45%诊断时为晚期(T3-4),71%需多模式治疗。
- 调查应答者中25% VHI-10升高提示持续语音困难,18% HADS升高提示抑郁。
- 年轻调查应答者存在对负面评价的恐惧。
- 调查和访谈中,心理支持是最期望的长期服务;受访者描述治疗后服务匮乏。
临床怎么用
- 头颈癌 survivorship 随访中应关注语音困难和抑郁筛查。
- 应将心理支持纳入长期服务规划。
- 需倡导增加治疗后支持服务。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding quality of life (QOL) after head and neck cancer (HNC) is crucial for service planning. This study explored survivorship experiences in New Zealand. METHODS: This study includes clinical records audit (n = 1277), cross-sectional online survey (n = 195), and semi-structured interviews (n = 22). Audit included all patients presenting to one tertiary cancer center (2012-2023). All 750 patients surviving > 12 months past primary treatment were invited to complete a survey. All survey respondents were offered follow-up interviews. RESULTS: Patients (male: 72%, 51-70 years: 45%; oral cavity 32%, oropharynx 21%) were often diagnosed at advanced stages (T3-4: 45%) requiring multimodal treatment (71%). Survey respondents reported persisting voice difficulties (25% elevated VHI-10) and depression (18% elevated HADS). Fear of negative evaluation was evident in younger survey respondents. Psychological support was the most desired long-term service in surveys and interviews. Interviewees described a paucity of services post-treatment. CONCLUSIONS: This study describes challenges accessing long-term support after HNC. Advocating for long-term support may enhance survivorship experiences.
引用
- Miles A, Thompson-Williams E, Wilson E, et al. Long-Term Quality of Life Outcomes After Head and Neck Cancer in New Zealand. Head Neck. 2025. PMID: 41036581. doi:10.1002/hed.70059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。